| Literature DB >> 32750193 |
Michaela K Thielen1, Cody K Vaneerd1, Manibarsha Goswami2, Erin E Carlson2, John F May1.
Abstract
One promising strategy to combat antibiotic-resistant bacteria is to develop compounds that block bacterial defenses against antibacterial conditions produced by the innate immune system. Salmonella enterica, which causes food-borne gastroenteritis and typhoid fever, requires histidine kinases (HKs) to resist innate immune defenses such as cationic antimicrobial peptides (CAMPs). Herein, we report that 2-aminobenzothiazoles block histidine kinase-dependent phenotypes in Salmonella enterica serotype Typhimurium. We found that 2-aminobenzothiazoles inhibited growth under low Mg2+ , a stressful condition that requires histidine kinase-mediated responses, and decreased expression of the virulence genes pagC and pagK. Furthermore, we discovered that 2-aminobenzothiazoles weaken Salmonella's resistance to polymyxin B and polymyxin E, which are last-line antibiotics and models for host defense CAMPs. These findings raise the possibilities that 2-aminobenzothiazoles can block HK-mediated bacterial defenses and can be used in combination with polymyxins to treat infections caused by Salmonella.Entities:
Keywords: Antibiotics; Salmonella enterica; histidine kinases; polymyxin; signal transduction
Mesh:
Substances:
Year: 2020 PMID: 32750193 PMCID: PMC7765688 DOI: 10.1002/cbic.202000422
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164